MedTrace Logo

Use of Ibuprofen to Prevent IUD Site Effects

NCT00243815 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 2019

Last updated 2006-10-17

No results posted yet for this study

Summary

This research will determine whether prophylactic use of ibuprofen can prevent common side effects of the copper intrauterine device (IUD) and prevent early removal of the device.

Conditions

  • IUD Removal

Interventions

DRUG

ibuprofen

Sponsors & Collaborators

  • Chilean Institute of Reproductive Medicine

    collaborator OTHER

  • Ministry of Health, Chile

    collaborator OTHER_GOV

  • FHI 360

    lead OTHER

Principal Investigators

  • David Hubacher, PhD · FHI 360

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-06-30
Completion
2004-11-30

Countries

  • Chile

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00243815 on ClinicalTrials.gov